Actym Therapeutics and Wacker Biotech Sign Manufacturing Contract for Actym's Lead Candidate for the Treatment of Solid Tumors
BERKELEY, Calif. and AMSTERDAM, Feb. 28, 2022 /PRNewswire/ -- Actym Therapeutics, a biotechnology company focused on the discovery and development...
Source: businessinsider.com